Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2003
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087389A2 Biologic modulations with nanoparticles
10/23/2003WO2003087383A1 Compositions for delivering enyzmes involved in amino acid metabolism using recombinant ademo-associated virus virons (raav virons), and method and use for treating aminoi acid metabolic disorders using such raav virons
10/23/2003WO2003087347A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/23/2003WO2003087346A1 Embryo modification and implantation
10/23/2003WO2003087344A1 New strains capable of producing conjugated linoleic acid, capsulated composition comprising them, and the preparation methods thereof
10/23/2003WO2003087327A2 Preservation of bioactive materials by freeze dried foam
10/23/2003WO2003087323A2 Biologic modulations with nanoparticles
10/23/2003WO2003087308A2 Use of interleukin-24 to treat ovarian cancer
10/23/2003WO2003087307A2 Use of interleukin-19 to treat cervical cancer
10/23/2003WO2003087287A1 Targeted controlled delivery compositions activated by changes in ph or salt concentration
10/23/2003WO2003087220A2 Solid emulsions based on thermoplastic elastomers
10/23/2003WO2003087197A1 Hydrogel with controllable mechanical chemical and biological properties and method for making same
10/23/2003WO2003087196A1 Thermogelling oligopeptide polymers
10/23/2003WO2003087195A2 Heterogeneous protein networks crosslinked with silicone-containing links, and methods for producing them
10/23/2003WO2003087164A1 Iron dextrin compounds for the treatment of iron deficiency anaemia
10/23/2003WO2003087156A2 Heterogeneous crosslinked protein networks and methods for producing them
10/23/2003WO2003087124A2 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells
10/23/2003WO2003087097A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
10/23/2003WO2003087021A2 Nanoparticle delivery systems and methods of use thereof
10/23/2003WO2003086491A2 Tissue defect dressings comprising a keratin network
10/23/2003WO2003086471A2 Lyophilized and liquid preparations comprising a polysaccharide derivative of camptothecin
10/23/2003WO2003086470A2 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/23/2003WO2003086469A1 Ethyl cellulose-containing veterinary sustained release injection
10/23/2003WO2003086468A1 Aqueous dispersible steryl ester compositions
10/23/2003WO2003086455A1 Immunoadjuvant
10/23/2003WO2003086444A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003WO2003086421A1 External preparations for enhancing cell activity
10/23/2003WO2003086419A1 Antibiotic/benzoyl peroxide dispenser
10/23/2003WO2003086405A1 Solid dispersion composition
10/23/2003WO2003086399A1 Medicaments containing steroids and a novel anticholinesterase drug
10/23/2003WO2003086392A2 Process for preparing a finely self-emulsifiable pharmaceutical composition
10/23/2003WO2003086382A1 Tnp-470 polymer conjugates and use thereof
10/23/2003WO2003086381A1 Ansamycin formulations and methods for producing and using same
10/23/2003WO2003086376A1 Patch and process for producing the same
10/23/2003WO2003086369A2 Stealthy polymeric biodegradable nanospheres and uses thereof
10/23/2003WO2003086368A1 Liquid compositions for soft sustained-release capsules and method for production thereof
10/23/2003WO2003086367A1 Low dose liquid entecavir formulations and use
10/23/2003WO2003086366A1 An improved modified release preparation
10/23/2003WO2003086364A1 Sustained release pharmaceutical prepartations and methods for producing the same
10/23/2003WO2003086363A1 Drug-complex microparticles and methods of making/using same
10/23/2003WO2003086358A1 Excipient for use in dry powder inhalation preparations
10/23/2003WO2003086354A1 Nanoparticulate megestrol formulations
10/23/2003WO2003086352A1 Pharmaceutical formulation comprising melatonin
10/23/2003WO2003086351A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003WO2003086350A1 Formoterol and mometasone aerosol formulations
10/23/2003WO2003086349A1 Formoterol and ciclesonide aerosol formulations
10/23/2003WO2003086348A1 Allergic dermatitis formulation and method of treatment
10/23/2003WO2003086332A1 Antimicrobial wash and carrier solutions, and uses thereof
10/23/2003WO2003086324A2 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003WO2003086318A2 Improved prodrugs of cc-1065 analogs
10/23/2003WO2003086312A2 Conjugates comprising cancer cell specific ligands, a sugar and cancer chemotherapeutic agents/boron neutron capture therapy agents, and uses thereof
10/23/2003WO2003086305A2 Biodegradable peg-based polymer formulations in ocular applications
10/23/2003WO2003086298A2 Use of interleukin-19 to treat ovarian cancer
10/23/2003WO2003086296A2 Treatment for type 1 diabetes before and after expression of predisposition markers.
10/23/2003WO2003086293A2 Pharmaceutical preparation for taste masking
10/23/2003WO2003086286A2 Treatment of type 1 diabetes before and after expression of predisposition markers
10/23/2003WO2003086284A2 Colon tumor specific binding peptides
10/23/2003WO2003086283A2 Metastasis modulating activity of highly sulfated oligosaccharides
10/23/2003WO2003086280A2 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003WO2003086273A2 Histone conjugates and uses thereof
10/23/2003WO2003086272A2 Ultrapure transferrin for pharmaceutical compositions
10/23/2003WO2003086267A2 Multi-phase, multi-compartment capsular system
10/23/2003WO2003086172A2 Method for tagging colonic residue
10/23/2003WO2003086104A1 Encapsulated agglomeration of microcapsules and method for the preparation thereof
10/23/2003WO2003086097A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003WO2003086078A1 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium
10/23/2003WO2003059392A3 Conjugate for treating prokaryotic infections
10/23/2003WO2003053325A3 Microencapsulation of drugs by solvent exchange
10/23/2003WO2003047518A3 Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof
10/23/2003WO2003041656A3 Soluble drug extended release system
10/23/2003WO2003040287A3 Isotope-coded affinity tag
10/23/2003WO2003040164A3 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/23/2003WO2003031466A3 Angiotensin peptide-carrier conjugates and uses thereof
10/23/2003WO2003017824A3 Method and apparatus for acne treatment
10/23/2003WO2003016469A3 Chemo-enzymatic synthesis of sialylated oligosaccharides
10/23/2003WO2003013421A3 Pharmaceutical composition comprising a water/oil/water double microemulsion incorporated in a solid support
10/23/2003WO2003000922A3 Chimeric immunomodulatory compounds and methods of using the same
10/23/2003WO2003000226A3 Pharmaceutical compositions containing polymer and drug assemblies
10/23/2003WO2003000201A3 Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications
10/23/2003WO2002097042A3 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/23/2003WO2002094248A3 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
10/23/2003WO2002092056A8 Compaction process for manufacture of sodium phenytoin dosage form
10/23/2003WO2002083708A3 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
10/23/2003WO2002074034A3 Novel medicament compositions based on anticholinergic agents and endothelin antagonists
10/23/2003WO2002068000A3 Polymeric imagable brachytherapy seed
10/23/2003WO2002044336B1 Method of making a protein polymer and uses of the polymer
10/23/2003WO2002036145A8 Kahalalide f formulation
10/23/2003WO2002034117A3 Multiple epitopes connected by a carrier
10/23/2003WO2001047562A8 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/23/2003WO2001005427A8 Psca: prostate stem cell antigen and uses thereof
10/23/2003US20030199678 Such that binding modifies TNF activity
10/23/2003US20030199677 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
10/23/2003US20030199672 Mixture of glucagon-like peptide-I (GLP-1) having a lipophilic substituent such as N-epsilon-tetradecanoyllysine, and a surfactant; treating obesity and non insulin-dependent diabetes mellitus (NIDDM); protracted profile of action
10/23/2003US20030199615 A water based thermosensitive self-gelling liquid comprising cationic polymer and a phosphates, free of insoluble particles, injectable thermo-setting slurry; injectable Bone Substitutes for repairing
10/23/2003US20030199593 For formulating pharmaceuticals, cosmetics or personal care such as shampoos and conditioners
10/23/2003US20030199538 Imidazoquinoline amines, imidazotetrahydroquinoline amines, imidazopyridine amines and other amines containing heterocyclic rings, a fatty acid and a hydrophobic, aprotic component miscible with fatty acid; useful for skin disorders
10/23/2003US20030199537 Macrocyclic lactone useful in immunosuppressant therapy
10/23/2003US20030199519 Prodrugs of CC-1065 analogs
10/23/2003US20030199509 For treatment of glaucoma and/or ocular hypertension
1 ... 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 ... 1712